obesity-995x60.png
FEATURED ARTICLES
Your Company Needs Compliance Expertise — But When And From Whom?
When should a biotech formalize compliance? Learn how risk, funding, clinical activity, and commercialization shape the right expertise and structure.
-
![Medicine, healthcare insurance-GettyImages-1369119541]( "Participant Payment — Make It Make Cents")
Participant Payment — Make It Make CentsParticipant payment practices and expectations vary wildly. With advocate T.J. Sharpe, explore why sponsors need to rethink how they appreciate participants' time, effort, and burden.
-
![GettyImages-2154021980-trial-payment-card-cost]( "The Cost Of Caution In Clinical Trial Participant Support")
The Cost Of Caution In Clinical Trial Participant SupportRegulatory uncertainty around participant payments can create practical barriers to participation. Explore how clearer protections can support appropriate reimbursement while preserving safeguards.
-
![GettyImages-681726866 patient, payment, reimbursement]( "Where Clinical Trial Reimbursement Gets Complicated")
Where Clinical Trial Reimbursement Gets ComplicatedLearn where participant reimbursement can break down in clinical trials and how clearer payment processes can reduce delays and unnecessary work for research sites.
SERVICES AND PRODUCTS
Explore the breadth of Altasciences’ expertise in clinical pharmacology studies, supporting regulatory submissions across a diverse range of therapeutic areas.
Managing clinical trial disclosure can be challenging with the ever-evolving regulatory landscape, and varying requirements across different jurisdictions and regulatory bodies. New and updated regulations need to be continuously monitored and assessed for potential impact on an organization, processes and overall strategy.
Ypsomed accelerates clinical progress by reducing barriers across clinical development, enabling earlier study readiness, greater visibility and more informed decisions.
Explore validated pain models and integrated early-phase services designed to characterize dose response, evaluate safety and efficacy, and support informed decisions in analgesic development.
DECODE, the Digital Endpoint Collaboration for Outcomes Development, is Ametris’ pre-competitive collaboration framework designed to help address shared clinical measurement challenges across the life sciences industry. In regulatory contexts where evidence expectations are high, digital measures must be meaningful to patients, scientifically valid, operationally feasible, and aligned with regulatory expectations. By supporting the development and validation of fit-for-purpose, patient-centered digital measures, DECODE helps transform real-world data into validated clinical evidence across clinical research programs.